Small pulmonary lesions--a challenge for thoracic surgery?

Area of Science:

• Pulmonology
• Thoracic Surgery
• Surgical Pathology

Background:

• Pulmonary hamartomas are benign lung tumors.
• Distinguishing hamartomas from malignant lesions like lung carcinomas and benign conditions like lymphoid hyperplasia is crucial for diagnosis and treatment planning.
• Understanding associated clinical features and risk factors is important for patient management.

Purpose of the Study:

• To analyze the diagnosis, clinical features, and surgical management of pulmonary hamartomas.
• To compare pulmonary hamartomas with peripheral T1 lung carcinomas and lymphoid hyperplasia.
• To evaluate the efficacy of different surgical procedures for hamartomas.

Main Methods:

• Retrospective analysis of 103 patients who underwent surgery for pulmonary hamartomas between 1995 and 2000.
• Inclusion of 36 patients with peripheral T1 lung carcinomas and 50 with lymphoid hyperplasia for comparison.
• Analysis of surgical procedures (enucleation, wedge resection, lobectomy), lesion characteristics, and clinical associations (smoking, asbestos exposure, chronic lung diseases).

Main Results:

• Pulmonary hamartomas were smaller than T1 lung carcinomas but larger than lymphoid hyperplasia.
• Heavy smoking was prevalent in hamartoma patients (75% men, 55% women).
• Enucleation (21%) and wedge resection (77%) were effective surgical treatments for hamartomas with no recurrences during follow-up.

Conclusions:

• Pulmonary hamartomas are benign lesions with clinical associations to malignant lung carcinomas and lymphoid hyperplasia.
• Both enucleation and wedge resection are effective surgical treatments for pulmonary hamartomas, yielding identical curative results.
• Lymphoid hyperplasia can impact the interpretation of metastatic disease in lung imaging.